Tag: EVIO

Debra BorchardtNovember 21, 2018
EVIO.jpg

4min00
Cannabis lab testing company EVIO Inc.  (OTCQB: EVIO) announced unaudited revenue for its fiscal 2018 fourth quarter ending September 30, 2018. Revenues from North American operations which includes company-owned laboratories in Oregon, California, Massachusetts, and Alberta, in addition to royalty revenues from licensed laboratories in Colorado and Florida, were $1.05 million. Evio said that it plans […]

StaffApril 19, 2018
daily_hit004-1280x533.png

7min00
Here is your Daily Hit of cannabis news for April 19, 2018: On The Site: GW Pharmaceuticals Inc. GW Pharmaceuticals Inc. (GWPH) continues to get closer and closer to FDA approval of its drug Epidiolex for the rare forms of epilepsy Lennox-Gastaut and Dravet Syndrome. Epidiolex is GW’s lead cannabinoid product candidate and is a pharmaceutical formulation […]

StaffMarch 7, 2018
daily_hit004-1280x533.png

5min00
This is your quick hit of news for March 7, 2018. Marapharm Ventures Inc. Marapharm Ventures (MRPHF)  gave a progress report on its Washington facility. The copany said that the rehabilitation of the cultivation site will be completed by the end of March. “During the renovation, we have worked closely with our architect and engineering […]

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.